发明名称 Enhancement of hematopoietic stem cell survival
摘要 A composition is disclosed that includes lin<SUP>-</SUP> cells that are characterized as expressing CD31, CD34 and CD105, and not expressing c-kit, wherein the composition comprises fewer than 20% of lineage committed cells. Methods are disclosed for isolating CD31<SUP>+</SUP>CD34<SUP>+</SUP>CD45<SUP>-</SUP>CD105<SUP>+</SUP>c-kit<SUP>-</SUP> cells. Methods for reconstituting hematopoiesis using compositions including CD31<SUP>+</SUP>CD34<SUP>+</SUP>CD105<SUP>+</SUP>CD45<SUP>-</SUP>kit<SUP>-</SUP> cells are also disclosed.
申请公布号 US2005208025(A1) 申请公布日期 2005.09.22
申请号 US20040511233 申请日期 2004.10.12
申请人 FLEMING WILLIAM H;LI BEI 发明人 FLEMING WILLIAM H.;LI BEI
分类号 A61K35/12;C12N5/02;C12N5/0789;(IPC1-7):A61K48/00;C12N5/08 主分类号 A61K35/12
代理机构 代理人
主权项
地址